Temozolomide Capsule
Product Images NDC 73043-011

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Temozolomide (NDC 73043-011). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Devatis, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Temo-100mg-5s (Temo 100mg 5s)

Temozolomide Capsules USP 100 mg per capsule label for oral administration by Devatis, Inc. The label states each capsule contains 100 mg temozolomide, with 5 capsules per package. It includes storage instructions to keep between 15 to 30°C in tight, light-resistant containers, and notes the product is made in Turkey and distributed by Devatis, Inc. in San Clemente, CA.*

FDA Label Image

Temo-140mg-5s (Temo 140mg 5s)

Label for Temozolomide capsules, USP, 140 mg per capsule, for oral administration, Rx only. The package contains 5 capsules. Label includes storage instructions, dosage guidance, and states the product is cytotoxic. Manufactured and distributed by Devatis, Inc., San Clemente, CA. Contains bar code and NDC 73043-014-05.*

FDA Label Image

Temo-180mg-5s (Temo 180mg 5s)

Temozolomide Capsules, USP, 180 mg per capsule, oral administration. The label indicates the package contains 5 capsules and highlights cytotoxic precautions. Distributed by Devatis, Inc., San Clemente, CA, and made in Turkey. Storage instructions specify 25°C with allowed excursions. The label includes dosage reminders and container information.*

FDA Label Image

Temo-20mg-5s (Temo 20mg 5s)

Temozolomide Capsules USP 20 mg per capsule oral dosage form, with a package containing 5 capsules. The label includes storage instructions, dosage guidance notes, and a barcode. Distributed by Devatis, Inc., San Clemente, CA. The label also indicates the product is cytotoxic and made in Turkey.*

FDA Label Image

Temo-250mg-5s (Temo 250mg 5s)

Temozolomide Capsules, USP 250 mg oral capsules in a package containing 5 capsules. The label is from Devatis, Inc., distributed in San Clemente, CA. It includes dosage instructions, storage conditions, and a barcode. The product is marked as cytotoxic and includes cautions to follow directions carefully, with labeling indicating it is made in Turkey.*

FDA Label Image

Temo-5mg-5s (Temo 5mg 5s)

Temozolomide 5 mg capsules, USP for oral administration. The label states it contains 5 capsules per package, emphasizing the cytotoxic nature of the drug and advising to read accompanying directions. Manufactured by Devatis, Inc., the label includes storage instructions and barcode.*

FDA Label Image

Kaplan-meier Curves (Temo Fig2)

A survival curve chart titled 'ITT Population: Overall Survival' comparing overall survival probability over time (in months) from randomization between two groups: RT + TMZ and RT Only. The chart shows a hazard ratio (HR) with 95% confidence interval and a log-rank p-value, illustrating better survival for the RT + TMZ group.*

FDA Label Image

Chemical-structure (Temo Structure)

Chemical structure of temozolomide showing a fused ring system with amide, nitrogen, oxygen, and methyl functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.